Estimate Recalculated Nov 8, 2024 09:38PM EST
Eric K Rowinsky has an estimated net worth of $17.3 Million. This is based on reported shares across multiple companies, which include BIOGEN INC., BIND Therapeutics, Inc, Verastem, Inc., NEOPROBE CORP, Fortress Biotech, Inc., ADVENTRX PHARMACEUTICALS INC, STEMLINE THERAPEUTICS INC, TAPESTRY PHARMACEUTICALS, INC, and IMCLONE SYSTEMS INC/DE.
Eric K Rowinsky's CIK is 0001318886
2015 was Eric K Rowinsky's most active year for acquiring shares with 10 total transactions. Eric K Rowinsky's most active month to acquire stocks was the month of May. 2015 was Eric K Rowinsky's most active year for disposing of shares, totalling 10 transactions. Eric K Rowinsky's most active month to dispose stocks was the month of February. 2015 saw Eric K Rowinsky paying a total of $1,395,780.06 for 232,608 shares, this is the most they've acquired in one year. In 2015 Eric K Rowinsky cashed out on 59,130 shares for a total of $10,685,355.03, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!